1. Home
  2. CSWC vs INVA Comparison

CSWC vs INVA Comparison

Compare CSWC & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSWC
  • INVA
  • Stock Information
  • Founded
  • CSWC 1961
  • INVA 1996
  • Country
  • CSWC United States
  • INVA United States
  • Employees
  • CSWC N/A
  • INVA N/A
  • Industry
  • CSWC Textiles
  • INVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CSWC Consumer Discretionary
  • INVA Health Care
  • Exchange
  • CSWC Nasdaq
  • INVA Nasdaq
  • Market Cap
  • CSWC 1.2B
  • INVA 1.1B
  • IPO Year
  • CSWC N/A
  • INVA 2004
  • Fundamental
  • Price
  • CSWC $20.54
  • INVA $21.43
  • Analyst Decision
  • CSWC Buy
  • INVA Buy
  • Analyst Count
  • CSWC 5
  • INVA 5
  • Target Price
  • CSWC $23.50
  • INVA $36.60
  • AVG Volume (30 Days)
  • CSWC 648.7K
  • INVA 936.7K
  • Earning Date
  • CSWC 11-03-2025
  • INVA 11-05-2025
  • Dividend Yield
  • CSWC 12.44%
  • INVA N/A
  • EPS Growth
  • CSWC N/A
  • INVA 53.96
  • EPS
  • CSWC 1.62
  • INVA 1.52
  • Revenue
  • CSWC $217,271,000.00
  • INVA $388,521,000.00
  • Revenue This Year
  • CSWC $14.60
  • INVA $7.98
  • Revenue Next Year
  • CSWC $10.75
  • INVA $11.60
  • P/E Ratio
  • CSWC $12.64
  • INVA $14.05
  • Revenue Growth
  • CSWC 11.39
  • INVA 10.14
  • 52 Week Low
  • CSWC $17.46
  • INVA $16.52
  • 52 Week High
  • CSWC $23.86
  • INVA $22.76
  • Technical
  • Relative Strength Index (RSI)
  • CSWC 44.90
  • INVA 65.89
  • Support Level
  • CSWC $20.20
  • INVA $21.81
  • Resistance Level
  • CSWC $21.07
  • INVA $22.51
  • Average True Range (ATR)
  • CSWC 0.42
  • INVA 0.78
  • MACD
  • CSWC 0.05
  • INVA 0.22
  • Stochastic Oscillator
  • CSWC 50.86
  • INVA 71.14

About CSWC Capital Southwest Corporation

Capital Southwest Corp is a U.S.-based investment company that specializes in providing customized financing to middle market companies across various industries. The company's investment objective is to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnerships with business owners, management teams, and financial sponsors. The company's portfolio may include senior debt, second lien, and subordinated debt, preferred stocks, common stocks, and warrants. The primary source company's revenue comprises interest income and dividend income from investments made as well as management fees.

About INVA Innoviva Inc.

Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.

Share on Social Networks: